<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>801</ReferenceId>
        <DateLastUpdated>2011-08-23-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11369792</PubmedId>
            <Abstract>Major histocompatibility complex (MHC) class I-restricted CD8(+) T cells play a critical role in the protective immunity against Mycobacterium tuberculosis (Mtb). However, only a few Mtb peptides recognized by MHC class Ia-restricted CD8(+) T cells have been identified. Information on epitopes recognized by class Ib-restricted T cells is even more limited. M3 is an MHC class Ib molecule that preferentially presents N-formylated peptides to CD8(+) T cells. Because bacteria initiate protein synthesis with N-formyl methionine, the unique binding specificity of M3 makes it especially suitable for presenting these particular bacterial epitopes. We have scanned the full sequence of the Mtb genome for NH2-terminal peptides that share features with other M3-binding peptides. Synthetic peptides corresponding to these sequences were tested for their ability to bind to M3 in an immunofluorescence-based peptide-binding assay. Four of the N-formylated Mtb peptides were able to elicit cytotoxic T lymphocytes (CTLs) from mice immunized with peptide-coated splenocytes. The Mtb peptide-specific, M3-restricted CTLs lysed the Mtb-infected macrophages effectively, suggesting that these N-formylated Mtb peptides are presented as the naturally processed epitopes by Mtb-infected cells. Furthermore, T cells from Mtb-infected lungs, spleen, and lymph nodes responded to N-formylated Mtb peptides in an M3-restricted manner. Taken together, our data suggest that M3-restricted T cells may participate in the immune response to Mtb.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>1213-20</ArticlePages>
            <ArticleTitle>Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Chun</LastName>
                    <ForeName>T</ForeName>
                </Author>
                <Author>
                    <LastName>Serbina</LastName>
                    <ForeName>N V</ForeName>
                </Author>
                <Author>
                    <LastName>Nolt</LastName>
                    <ForeName>D</ForeName>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>B</ForeName>
                </Author>
                <Author>
                    <LastName>Chiu</LastName>
                    <ForeName>N M</ForeName>
                </Author>
                <Author>
                    <LastName>Flynn</LastName>
                    <ForeName>J L</ForeName>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>C R</ForeName>
                </Author>
            </Authors>
            <Affiliations>Gwen Knapp Center for Lupus and Immunology Research, Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois 60637, USA.</Affiliations>
            <ArticleChemicalList>Antigens, Bacterial;Histocompatibility Antigens Class I;Oligopeptides;N-Formylmethionine;Interferon-gamma</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antigens, Bacterial(immunology); Genome, Bacterial; Histocompatibility Antigens Class I(immunology); Interferon-gamma(secretion); Macrophages(immunology; microbiology); Mice; Mycobacterium tuberculosis(immunology); N-Formylmethionine(immunology); Oligopeptides(immunology); Phenotype; T-Lymphocytes, Cytotoxic(immunology); Tuberculosis(immunology)</ArticleMeshHeadingsList>
            <Comments>11369794  J Exp Med. 2001 May 21;193(10):F35-9</Comments>
            <Journal>
                <Volume>193</Volume>
                <Issue>10</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>1540-9538</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>TB2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MLVLLV</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1449274</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>42086</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Hydrophobic protein; contains β-ketoacyl synthase active site</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>9983</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MLVLLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>1449274</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB2</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MLVLLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>1449274</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Bone Marrow</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed macrophages infected with Mycobacterium tuberculosis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3C</LocationOfData>
                        <TCellId>8574</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000072</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were innoculated intravenously in the tail vein with live bacilli. At 21 d after infection, spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MLVLLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1449274</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Splenocytes from infected mice produced IFN-γ in response to P388-M3 pulsed with peptide. Splenocytes from infected C57BL/6 mice also produced IFN-γ.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>8573</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MLVLLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>1449274</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB2</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MLVLLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>1449274</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MLVLLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1449274</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested produced IFN-γ by ELISA.  One of the CTL lines expressed the Vα3+ and Vβ8+ segments of the T cell receptor, while the other expressed the Vα11+ and Vβ6+ segments of the T cell receptor.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <TCellId>8564</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MLVLLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>1449274</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB2</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MLVLLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>1449274</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MLVLLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1449274</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed M3wt-transfected TR8.4a (H2-M3wt) fibroblast cell lines presenting peptide as well as lysing the macrophage cell line, P388 (H-2d, H2-M3wt). Both of the two CTL lines tested also lysed macrophages infected with Mycobacterium tuberculosis. Cross-reactivity was seen as one CTL line (6A, stimulated by the TB6 peptide in vitro) and another CTL line (7A, stimulated by the TB7 peptide in vitro) lysed the target cell line P388 coated with the TB2 peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>8560</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TB4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MFLIDV</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>2909466</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41510</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Conserved hypothetical protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <TCellId>9525</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFLIDV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2909466</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFLIDV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2909466</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MFLIDV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>2909466</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed the M3wt-transfected TR8.4a (H2-M3wt) fibroblast cell line presenting the peptide as well as lysing the macrophage cell line, P388 (H-2d, H2-M3wt) and macrophages infected with Mycobacterium tuberculosis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>9526</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFLIDV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2909466</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFLIDV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2909466</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MFLIDV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>2909466</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested produced IFN-γ by ELISA. One of the CTL lines expressed the Vα2+ and Vβ14+ segments of the T cell receptor, while the other expressed the Vβ8+ segment of the T cell receptor.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3C</LocationOfData>
                        <TCellId>9527</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000072</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were innoculated intravenously in the tail vein with live bacilli. At 21 d after infection, spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB4</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MFLIDV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>2909466</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Splenocytes from infected mice produced IFN-γ in response to P388-M3 pulsed with peptide. Splenocytes from infected C57BL/6 mice also produced IFN-γ.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>9989</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFLIDV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2909466</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFLIDV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>6</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2909466</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Bone Marrow</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed macrophages infected with Mycobacterium tuberculosis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9528</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TB6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MFFLDA</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <SourceMolecule>
                            <IedbAccession>SRC7531</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41496</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <TCellId>9535</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFFLDA</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC7531</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB6</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFFLDA</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC7531</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MFFLDA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <SourceMolecule>
                                            <IedbAccession>SRC7531</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed the M3wt-transfected TR8.4a (H2-M3wt) fibroblast cell line presenting the peptide. Two CTL cell lines also lysed the macrophage cell line, P388 (H-2d, H2-M3wt) as well as macrophages infected with Mycobacterium tuberculosis. Cross-reactivity was seen as one CTL line (2B, stimulated by the TB2 peptide in vitro) and another CTL line (4B, stimulated by the TB4 peptide in vitro) both lysed the target cell line P388 coated with the TB6 peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>9990</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFFLDA</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC7531</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB6</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFFLDA</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC7531</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Bone Marrow</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed macrophages infected with Mycobacterium tuberculosis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>9536</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFFLDA</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC7531</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB6</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MFFLDA</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC7531</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MFFLDA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <SourceMolecule>
                                            <IedbAccession>SRC7531</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested produced IFN-γ by ELISA. One of the CTL lines expressed the Vα2+ and Vβ10+ segments of the T cell receptor, while the other expressed the Vα2+ segment of the T cell receptor.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3C</LocationOfData>
                        <TCellId>9537</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000072</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were innoculated intravenously in the tail vein with live bacilli. At 21 d after infection, spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MFFLDA</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <SourceMolecule>
                                            <IedbAccession>SRC7531</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Splenocytes from infected mice produced IFN-γ in response to P388-M3 pulsed with peptide. Splenocytes from infected C57BL/6 mice also produced IFN-γ.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9538</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TB7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MILLV</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>5</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>2326729</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41740</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>5</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Probable transmembrane protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table II</LocationOfData>
                        <TCellId>9540</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MILLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>5</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2326729</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB7</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MILLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>5</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2326729</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB7</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MILLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>5</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>2326729</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested produced IFN-γ by ELISA. One of the CTL lines expressed the Vβ5+ segment of the T cell receptor, while the other expressed the Vα3+ and Vβ5+ segments of the T cell receptor.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <TCellId>9539</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MILLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>5</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2326729</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB7</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MILLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>5</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2326729</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB7</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MILLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>5</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>2326729</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed the M3wt-transfected TR8.4a (H2-M3wt) fibroblast cell line presenting the peptide as well as lysing the macrophage cell line, P388 (H-2d, H2-M3wt) and macrophages infected with Mycobacterium tuberculosis. Cross-reactivity was seen as one CTL line (6A, stimulated by the TB6 peptide in vitro) lysed the target cell line P388 coated with the TB7 peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3C</LocationOfData>
                        <TCellId>9541</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000072</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were innoculated intravenously in the tail vein with live bacilli. At 21 d after infection, spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB7</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MILLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>5</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>2326729</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Splenocytes from infected mice produced IFN-γ in response to P388-M3 pulsed with peptide. Splenocytes from infected C57BL/6 mice also produced IFN-γ.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>9991</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MILLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>5</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2326729</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TB7</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>1</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MILLV</LinearSequence>
                                            <ModifiedResidues>M1</ModifiedResidues>
                                            <Modifications>Formylation|FORM</Modifications>
                                            <StartingPosition>1</StartingPosition>
                                            <EndingPosition>5</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>2326729</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were innoculated with irradiated, syngeneic peptide-coated splenocytes through intraperitoneal injection and footpad infection. After 1 wk, long-term CTL lines were developed from splenocytes stimulated with peptide-pulsed syngeneic splenocytes.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Bone Marrow</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                            <SourceOrganismId>32644</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Both of the two CTL lines tested lysed macrophages infected with Mycobacterium tuberculosis.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9542</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TB1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MIVVLV</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>1870007</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41792</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Conserved hypothetical protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3C</LocationOfData>
                        <TCellId>9545</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000072</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>83332</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were innoculated intravenously in the tail vein with live bacilli. At 21 d after infection, spleens were harvested.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10090</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>TB1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIVVLV</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>1870007</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>83332</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Splenocytes from infected mice produced IFN-γ in response to P388-M3 pulsed with peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9546</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TB3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MWYYLF</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>15609319</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>43032</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Conserved hypothetical protein. Contains hypothetical ATP/GTP binding site.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9548</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TB5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MLFAAL</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>3261618</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>83332</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41934</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>ABC-transporter transmembrane subunit.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9549</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Fr38</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MIVIL</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>5</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>16411031</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1639</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41789</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>5</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9978</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>LemA</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MIGWII</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>81509756</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>169963</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41710</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9979</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ND1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MFFINIL</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>7</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>57015344</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41491</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>7</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9980</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>COI</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MFINRW</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>116982</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>41505</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>9982</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>185</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P388-M3 is a macrophage cell line that has been transfected with M3 cDNA under control of the CMV promoter.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>128</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

